Amazon Reviews Supplier Costs as U.S.–China Tariffs Ease 
Nvidia Denies Upfront Payment Requirement for H200 AI Chips Amid China Export Scrutiny 
Vitol to Ship First U.S. Naphtha Cargo to Venezuela Under New Oil Supply Deal 
AFT Leaves X Over AI-Generated Images of Minors 
Anthropic Launches HIPAA-Compliant Healthcare Tools for Claude AI Amid Growing Competition 
AbbVie Commits $100 Billion to U.S. Investment in Drug Pricing Deal With Trump Administration 
SK Hynix to Invest $13 Billion in Advanced Chip Packaging Plant as AI Memory Demand Surges 
Allegiant to Acquire Sun Country Airlines in $1.5 Billion Deal to Expand U.S. Leisure Travel Network 
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market 
Trump Weighs Blocking Exxon Investment as Venezuela Deemed “Uninvestable” 
Taiwan Issues Arrest Warrant for OnePlus CEO Over Alleged Illegal Recruitment Activities 
Trump Considers Starlink to Restore Internet Access in Iran Amid Protests 
Tesla, EEOC Move Toward Mediation in Racial Harassment Lawsuit 
Trump Administration Approves Nvidia H200 AI Chip Sales to China Under New Export Rules 
Netflix Plans All-Cash Bid for Warner Bros Discovery Studios Amid Intense Hollywood Takeover Battle 
Coca-Cola Shelves Costa Coffee Sale After Low Private Equity Offers 
HSBC Expands UAE Presence With New Asset Management Business and Onshore Funds 
SAN FRANCISCO, March 29, 2017 -- Hagens Berman Sobol Shapiro LLP reminds investors in Chicago Bridge & Iron Company N.V. (NYSE:CBI) of the May 1, 2017 Lead Plaintiff deadline in the pending securities class action.
If you purchased or otherwise acquired securities of CBI between October 29, 2013 and December 10, 2014 and suffered losses contact Hagens Berman Sobol Shapiro LLP. For more information visit:
https://www.hbsslaw.com/cases/CBI
or contact Reed Kathrein, who is leading the firm’s investigation, by calling 510-725-3000 or emailing [email protected].
The securities class action concerns the Company’s February 2013 acquisition of – and related accounting for – a business known as The Shaw Group. Through the Shaw acquisition, CBI would acquire purportedly high-value contracts to complete construction of new nuclear power plants that included Plant Vogtle.
On June 17, 2014, Prescience Point issued a report entitled “Acquisition Accounting Gone Nuclear” concluding that defendants misstated the Company’s previously reported balance sheet, income from operations and earnings per share through inappropriate acquisition accounting for Shaw. This news drove the price of CBI shares down over 8% to close at $68.26 that day.
On December 10, 2014, TradeFair Group reported that longer delays are likely for the Vogtle reactors. Between December 7, 2014 and December 12, 2014, as the market digested this information, the price of CBI’s shares fell almost 15% to close at $39.14 on December 12.
“We’re focused on what may be serious violations of generally accepted accounting principles in connection with the Company’s business combination with Shaw that, if true, had a material impact on CBI’s financial condition,” said Hagens Berman partner Reed Kathrein.
Whistleblowers: Persons with non-public information regarding CBI should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new SEC whistleblower program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email [email protected].
About Hagens Berman
Hagens Berman is a national investor-rights law firm headquartered in Seattle, Washington with offices in 10 cities. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the Firm and its successes can be found at www.hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.
Contact: Reed Kathrein, 510-725-3000
